Doctors offer new minimally invasive system to treat patients with stenosis in aortic heart failure -
Doctors at Orlando Health Heart Institute offers a new mini system -invasive to treat patients with stricture, failing aortic heart valves who are considered at high risk for surgery. Orlando Health is the only hospital in Orlando currently offers the Medtronic CoreValve® system.
"means the system of patients with disease of the aortic valve that are considered high-risk for surgery, now have a new option," said Deepak Vivek, MD, interventional cardiologist and Director , cardiovascular Institute Orlando Valve Center. "Patients no longer have to live with chest pain, shortness of breath, fatigue and other symptoms of aortic stenosis or treatment options that can not provide lasting results. Patients have more to live without hope of improvement. We are excited to bring advanced technology to improve outcomes for our patients. "
The CoreValve system was originally approved by the US Food and Drug Administration (FDA) in January 2014 to treat patients who are too sick or weak to undergo surgery. With this latest approval, the Orlando health heart Institute now offers the CoreValve system for patients who are considered high risk for surgical cardiac procedures, serving a wide range of American patients than any other transcatheter aortic valve.
FDA approved the CoreValve system to treat patients with severe aortic stenosis who are at high risk for surgery based on advanced research showing the transcatheter heart valve had higher survival rate at one year compared to to heart surgery open, the current gold standard aortic valve replacement. the CoreValve system has also demonstrated rates of procedural complications, including stroke, one of the most concerning valve replacement complications because can affect the survival and quality of low life.
The CoreValve system replaces a diseased aortic heart valve through a minimally invasive procedure, without open heart surgery and without surgical removal of the diseased valve. The device is usually inserted through an artery in the leg or chest and then guided through the arteries in the heart. Once in place, the CoreValve system develops and supports the function of the original valve to allow oxygen-rich blood to circulate efficiently on the heart.
The advanced design of the CoreValve system is suitable for patients with native valves of almost any size, and it comes with the smallest delivery system available to treat patients with vascular systems that are small or difficult to navigate. In addition, part of the self-expansion of the valve allows physicians to provide the device in a controlled manner, allowing precise positioning.
Aortic stenosis is a common heart problem caused by a narrowing of the aortic valve of the heart due to excessive calcium deposited on the valve leaflets. When the valve narrows, it does not open or close properly, which makes the work of the heart muscle to pump blood throughout the body. Eventually, this causes the heart to weaken and malfunction, which can lead to heart failure and increased risk of sudden cardiac death.
EmoticonEmoticon